Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | PI4KA | P42356 | 1/20 | 0.46 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.46 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.46 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | FGFR1 | P11362 | 5/20 | 0.43 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 2/20 | 0.40 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.40 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.40 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30269650 | 1.00 | EGFR (0.46) | EGFRPI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL30269607 | 0.79 | XDH (0.48) | FGFR1XDHALDH1A1SMN1; SMN2 | |
| SCHEMBL1858815 | 0.74 | HTT (0.58) | HTTFGFR1SRCHCAR1 | |
| SCHEMBL4352301 | 0.74 | HTT (0.58) | HTTFGFR1SRC | |
| SCHEMBL7033144 | 0.73 | HTT (0.52) | EGFRPI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL3236039 | 0.69 | EGFR (0.51) | EGFRPI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL25878225 | 0.67 | PI4KA (0.49) | EGFRPI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL2210667 | 0.66 | KDM4E (0.43) | PI4KAPI4K2BPI4K2API4KBHTT | |
| SCHEMBL29596321 | 0.66 | TDP1 (0.32) | — | |
| SCHEMBL4499130 | 0.66 | MEN1 (0.53) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | CITY UNIVERSITY OF HONG KONG (HK) | 2023-01-05 | — | — | US | disclosed |
| US-20220402955-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | CITY UNIVERSITY OF HONG KONG (HK) | 2022-12-22 | — | — | US | disclosed |
| US-11444254-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2022-09-13 | — | — | US | disclosed |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2021-04-29 | — | — | US | disclosed |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2021-04-29 | — | — | US | disclosed |
| US-9487548-B2 | Metal complexes comprising diazabenzimidazolocarbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2016-11-08 | — | — | US | disclosed |
| US-9487548-B2 | Metal complexes comprising diazabenzimidazolocarbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2016-11-08 | — | — | US | disclosed |
| EP-2513125-B1 | METAL COMPLEXES WITH DIAZABENZIMIDAZOLECARBENE LIGANDS AND THEIR USE IN OLEDS | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| EP-2513125-B1 | METAL COMPLEXES WITH DIAZABENZIMIDAZOLECARBENE LIGANDS AND THEIR USE IN OLEDS | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| EP-2513125-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011073149-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-06-23 | — | — | WO | disclosed |
| US-4273862-A | ANIONIC CYANINE DYE, HYDROQUINONE FRBRLOPRT | MITSUBISHI PAPER MILLS, LTD. (JP) | 1981-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, DRD2 | EGFR 2132/4885PI4KA 1792/4885PI4K2B 1723/4885 |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | EGFR 2094/4885PI4KA 1725/4885PI4K2B 1658/4885 |
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | OCIAD1, OCIAD2, OPRD1 | EGFR 3630/4885PI4KA 3911/4885PI4K2B 4050/4885 |
| US-20220402955-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | OCIAD1, OCIAD2, OSTC | EGFR 3470/4885PI4KA 3558/4885PI4K2B 3683/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | EGFR 2094/4885PI4KA 1725/4885PI4K2B 1658/4885 |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | EGFR 2094/4885PI4KA 1725/4885PI4K2B 1658/4885 |
| US-11444254-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDs | OCIAD1, OCIAD2, DRD2 | EGFR 2094/4885PI4KA 1725/4885PI4K2B 1658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.